Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 200

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 200
---
 therein, including compliance with Nasdaq rules and having obtained the prior written consent of the holder of such warrant.

In the event of stock dividends and splits, the number of shares of Common Stock issuable upon the exercise of the September 2025 Warrants will also be adjusted so that the aggregate exercise price shall be the same immediately before and immediately after any such adjustment.

#### Cashless Exercise
If at the time of exercise of the September 2025 Warrants, there is no effective registration statement available for the resale of the shares of our Common Stock underlying the September 2025 Warrants, such warrants may be exercised on a cashless basis pursuant to their terms.

#### Limitations on Exercise
A holder shall not have the right to exercise any portion of a September 2025 Warrant to the extent that, after giving effect to such conversion, the holder (together with certain of its related parties) would beneficially own in excess of 4.99% of shares of our Common Stock outstanding immediately after giving effect to such exercise. Such maximum percentage may be raised or lowered to any other percentage not in excess of 9.99%, at the option of the holder, except that any increase will only be effective upon 61 days’ prior notice to us.

#### Exercise Period
The September 2025 Warrants were immediately exercisable upon issuance, and will be exercisable until the September 2025 Warrant expiration date of December 13, 2029.

#### Purchase and Distribution Rights
If we (i) issue or sell Purchase Rights pro rata to the record holders of our common stock or (ii) declare or make any Distribution, then, in each case, a holder of September 2025 Warrants will, upon each exercise of a September 2025 Warrant, be entitled to participate in such issuance or sale of Purchase Rights or Distribution, as

<div align='center'>125</div>

applicable, to the same extent that the holder would have participated therein if the holder had held the number of shares of our Common Stock the holder acquired upon each such exercise immediately before the date on which a record is taken for such issuance or sale of Purchase Rights or Distribution.

#### Fundamental Transactions
The September 2025 Warrants prohibit us from entering into specified fundamental transactions unless the successor entity (subject to certain exceptions) assumes all of our obligations under the September 2025 Warrants under a written agreement before the transaction is completed and the successor entity is a publicly traded company.

Upon specified corporate events,